⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5653717 | 0.82 | CES2 (0.32) | — | |
| SCHEMBL16144914 | 0.82 | CES2 (0.32) | — | |
| SCHEMBL15081202 | 0.79 | — | — | |
| SCHEMBL11918117 | 0.79 | — | — | |
| SCHEMBL4077275 | 0.78 | CES2 (0.43) | — | |
| SCHEMBL25815236 | 0.77 | — | — | |
| SCHEMBL22624129 | 0.76 | — | — | |
| SCHEMBL8375997 | 0.75 | — | — | |
| SCHEMBL13555443 | 0.75 | — | — | |
| SCHEMBL2002186 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022143262-A1 | ENERGY STORAGE DEVICE | 广东微电新能源有限公司 | 2022-07-07 | — | — | WO | claimed |
| WO-2024034522-A1 | ADDITIVE FOR NON-AQUEOUS ELECTROLYTIC SOLUTION, NON-AQUEOUS ELECTROLYTIC SOLUTION, AND POWER STORAGE DEVICE | 住友精化株式会社 | 2024-02-15 | — | — | WO | disclosed |
| US-20210093618-A1 | SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF | GENENTECH, INC. (US) | 2021-04-01 | — | — | US | disclosed |
| US-9522906-B2 | Tetrahydroquinoline analogues as muscarinic agonists | ACADIA PHARMACEUTICALS, INC. (US) | 2016-12-20 | — | — | US | disclosed |
| EP-2611300-B1 | SUBSTITUTED ANNELATED DIHYDROPYRIMIDINONE COMPOUNDS | BAYER IP GMBH (DE) | 2016-04-06 | — | — | EP | disclosed |
| US-20140221364-A1 | TETRAHYDROQUINOLINE ANALOGUES AS MUSCARINIC AGONISTS | ACADIA PHARMACEUTICALS, INC. (US) | 2014-08-07 | — | — | US | disclosed |
| CN-102471252-B | Process for producing (fluoroalkylthio) acetic acid ester | SUMITOMO CHEMICAL CO | 2014-07-02 | — | — | CN | disclosed |
| CN-103709079-A | Process for preparation of (fluoroalkylthio)acetic acid esters | MASAJI HIROTA HIROYUKI MIYAZAKI TADAYOSHI ITOH | 2014-04-09 | — | — | CN | disclosed |
| US-8680115-B2 | Tetrahydroquinoline analogues as muscarinic agonists | ACADIA PHARMACEUTICALS, INC. (US) | 2014-03-25 | — | — | US | disclosed |
| EP-2684870-A1 | METHOD FOR PREPARING THIOCARBOXYLIC ACID S-(FLUOROALKYL) ESTER | Sumitomo Chemical Company Limited (JP) | 2014-01-15 | — | — | EP | disclosed |
| CN-101027048-A | Medicinal composition as immunosuppressant | SANKYO CO (JP) | 2007-08-29 | — | — | CN | disclosed |
| US-20070149597-A1 | Medicinal composition as immunosuppressant | SANKYO COMPANY, LIMITED (JP) | 2007-06-28 | — | — | US | disclosed |
| EP-1782804-A1 | MEDICINAL COMPOSITION AS IMMUNOSUPPRESSANT | Sankyo Company, Limited (JP) | 2007-05-09 | — | — | EP | disclosed |
| US-7160875-B2 | Malonamide derivatives | HOFFMANN-LA RACHE INC. (US) | 2007-01-09 | — | — | US | disclosed |
| US-7160875-B2 | Malonamide derivatives | HOFFMANN-LA RACHE INC. (US) | 2007-01-09 | — | — | US | disclosed |
| CN-1223561-C | Compound having tetrahydronalphthalene skeleton and liquid crystal compsn. contg. same | DAINIPPON INK & CHEMICALS (JP) | 2005-10-19 | — | — | CN | disclosed |
| WO-2005023772-A1 | MALONAMIDE DERIVATIVES BLOCKING THE ACTIVITY OF GAMA-SECRETASE | F. HOFFMANN-LA ROCHE AG (CH) | 2005-03-17 | — | — | WO | disclosed |
| CN-1356969-A | Compound having tetrahydronalphthalene skeleton and liquid crystal compsn. contg. same | DAINIPPON INK & CHEMICALS (JP) | 2002-07-03 | — | — | CN | disclosed |
| CN-1075143-A | Optically active azole compounds | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1993-08-11 | — | — | CN | disclosed |
| CN-1072680-A | Optically active azole compounds and method for making thereof and purposes | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1993-06-02 | — | — | CN | disclosed |